The Scientist

» Big Pharma

Most Recent

image: Dengue Vaccine Program Halted Over Safety Issues

Dengue Vaccine Program Halted Over Safety Issues

By | December 5, 2017

The drug may worsen future infections for people who haven't already been exposed to the virus.

0 Comments

The Good Pharma Scorecard finds some big pharmaceutical companies are meeting legal standards for disclosing results—but many studies still go unreported.

0 Comments

image: Takeda to Buy Cancer Drug Maker Ariad for $5.2 Billion

Takeda to Buy Cancer Drug Maker Ariad for $5.2 Billion

By | January 10, 2017

The pharma giant’s purchase of the US firm includes the acquisition of investigative cancer drugs.

0 Comments

image: TS Picks: August 9, 2016

TS Picks: August 9, 2016

By | August 9, 2016

Gene therapy money-back guarantee; the brain benefits from bilingualism; Q&A with a science watchdog

0 Comments

image: Pfizer Scoops Anacor for $5.3 Billion

Pfizer Scoops Anacor for $5.3 Billion

By | May 17, 2016

The acquisition-hungry pharmaceutical firm is purchasing the California-based eczema gel maker.

0 Comments

image: Bayer Enters CRISPR Field

Bayer Enters CRISPR Field

By | December 22, 2015

The pharmaceutical company will spend $335 million on a new venture with biotech startup CRISPR Therapeutics.

0 Comments

image: Pfizer and Allergan to Merge

Pfizer and Allergan to Merge

By | November 23, 2015

The two drugmakers will join forces in a $160 billion deal—if it’s given the regulatory green light.

0 Comments

image: Shire Buys Rare Disease Drug Developer

Shire Buys Rare Disease Drug Developer

By | November 2, 2015

The Irish drugmaker is set to acquire the Massachusetts-based Dyax in a $5.9 billion deal.

0 Comments

image: Hearing Help

Hearing Help

By | September 1, 2015

For decades, the only remedies for hearing loss were devices such as hearing aids or cochlear implants. Now, the first pharmaceutical treatments may be on the way.  

2 Comments

image: Legionnaires’ Bacteria at GSK

Legionnaires’ Bacteria at GSK

By | August 14, 2015

GlaxoSmithKline temporarily shuts down a manufacturing plant in North Carolina after Legionella bacteria are detected in two external cooling towers.

0 Comments

Popular Now

  1. Secret Eugenics Conference Uncovered at University College London
  2. How Do Infant Immune Systems Learn to Tolerate Gut Bacteria?
  3. That Other CRISPR Patent Dispute
    Daily News That Other CRISPR Patent Dispute

    The Broad Institute and Rockefeller University disagree over which scientists should be named as inventors on certain patents involving the gene-editing technology.

  4. DOE-Sponsored Oak Ridge National Laboratory to Cut 100 More Jobs
AAAS